Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David J. Wambeke currently holds 500,000 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Wambeke has been a net buyer of DMAC stock. They have purchased $1.6M and sold $0 worth of shares.
David J. Wambeke's most recent insider trade was on Mar 1, 2026, when they sold 500,000 shares at $0.00 per share.
David J. Wambeke serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 6 insider transactions totaling $1.6M over their tenure at the company.
David J. Wambeke holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
David J. Wambeke has shown a buying trading pattern, with $1.6M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David J. Wambeke was on Apr 10, 2023, when they purchased $750.0K worth of DMAC shares. This transaction involved 468,750 shares at $1.60 per share.
David J. Wambeke currently owns 500,000 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David J. Wambeke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David J. Wambeke has 6 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for David J. Wambeke and 40,000+ other insiders.